Our top priority is providing value to members. Your Member Services team is here to ensure you maximize your 番茄社区app member benefits, participate in College activities, and engage with your 番茄社区app colleagues. It's all here.
Become a MemberOur top priority is providing value to members. Your Member Services team is here to ensure you maximize your 番茄社区app member benefits, participate in College activities, and engage with your 番茄社区app colleagues. It's all here.
Become a MemberApril 18, 2024
Researchers from the聽, the聽聽Cancer Action Network and peer institutions released new findings in the聽聽showing that when all types of cancer research studies are considered, at least one-in-five people with cancer, or 21.9%, participate in some form of clinical research.
Using deidentified accreditation data from the聽CoC, the study evaluated all categories of cancer studies, such as treatment trials, biorepository studies, and quality of life studies鈥攖he first time an estimate of participation in all types of cancer studies has been reported. Moreover, enrollment in cancer treatment trials was 7.1%, a notably higher participation rate than previous estimates of 2%-3%.
The study also found that enrollment in treatment trials was more than five-fold higher at National Cancer Institute-designated cancer centers than at community sites (21.6% versus 4.1%), reflecting the impact that NCI funding for staff and infrastructure has on an institution鈥檚 ability to offer trials and recruit patients.